Return to The CPNP Perspective issue main page.< Previous Article
Board officer and committee transitions were announced at CPNP 2019 with CPNP President Megan Ehret, PharmD, MS, BCPP, Associate Professor, University of Maryland, Baltimore, MD, passing the gavel to President-Elect Lisa Goldstone, PharmD, BCPS, BCPP, Associate Professor of Clinical Pharmacy/Associate Director of Residency Programs, University of Southern California School of Pharmacy, Los Angeles, CA. Also recognized as new President-Elect was Marshall Cates, PharmD, BCPP, FASHP, FCCP, Professor & Chair, Department of Pharmacy Practice, Samford University McWhorter School of Pharmacy, Birmingham, AL. All will transition their duties beginning in July of 2019.
 
In addition to the three officers above, the following individuals will serve on the CPNP Board during 2019-2020:
  • Ericka Crouse, PharmD, BCGP, BCPP, FASCP, FASHP, Associate Professor, Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA
  • Karen Moeller, PharmD, BCPP, Clinical Associate Professor, University of Kansas School of Pharmacy, Kansas City, KS
  • Tawny Smith, PharmD, BCPP, Associate Professor of Psychiatry, The University of Texas at Austin, Dell Medical School, Austin, TX
  • Heidi Wehring, PharmD, BCPP, Assistant Professor of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD

Departing from the Board as of June 30, 2019 are:

  • Benjamin Chavez, PharmD, BCPP, BCACP, Associate Professor, University of Colorado Skaggs School of Pharmacy, Aurora, CO
  • Deanna Kelly, PharmD, BCPP, Professor, University of Maryland, Baltimore, MD
  • Amy Werremeyer, PharmD, BCPP, Associate Professor, Dept. of Pharmacy Practice; Clinical Specialist in Psychiatry, North Dakota State University, Fargo, ND

Also installed at the Annual Meeting were 2019-2020 Committee Chairs for CPNP as follows:

  • Abstracts and Awards Committee: Julie Cunningham, PharmD, BCPP, Pharmacotherapy coordinator, Mayo Medical Clinic, Rochester, MN
  • Business Development Council: Steve Stoner, PharmD, BCPP, Clinical Professor and Chair, University of Missouri at Kansas City, Kansas City, MO
  • From Theory to Practice Case Series: Michael McGuire, PharmD, BCPP, Assistant Professor of Pharmacy Practice, Belmont University, Nashville, TN
  • Government Affairs Council: Carla Cobb, PharmD, BCPP, Psychiatric Pharmacist, Capita Consulting, Billings, MT
  • Mental Health Clinician Editorial Board: Amy VandenBerg, PharmD, BCPP, Clinical Specialist, Michigan Medicine, Ann Arbor, MI and Clint Ross, PharmD, BCPP, Psychiatric Clinical Pharmacy Specialist, Medical University of South Carolina, Charleston, SC
  • Past President’s Council: Megan Ehret, PharmD, MS, BCPP, Associate Professor, University of Maryland, Baltimore, MD
  • Professional Affairs Council: Carla Cobb, PharmD, BCPP, Psychiatric Pharmacist, Capita Consulting, Billings, MT
  • Program Committee: Robert Haight, PharmD, BCPP, Clinical Pharmacy Specialist-Psychiatry, University of MN Medical Center, Minneapolis, MN
  • Psychopharmacology Pearls: Beth Hall, PharmD, BCPP, Regional Pharmacy Practice Manager, SSM Health, Jefferson City, MO
  • Public Education Committee (formerly Consumer Relations): Dara Johnson, PharmD, BCPP, Clinical Pharmacy Specialist, Providence Medical Group, Portland, OR
  • Recertification Editorial Board: Sarah Melton, PharmD, BCPP, BCACP, Associate Professor, Gatton College of Pharmacy, Johnson City, TN
  • Resident and New Practitioner Committee: Andrew Williams, PharmD, BCPP, BCGP, Clinical Pharmacist, Riverside University Health System, Riverside, CA
  • Review Course Editorial Board: Megan Ehret, PharmD, MS, BCPP, Associate Professor, University of Maryland, Baltimore, MD, Carol Ott, PharmD, BCPP, Clinical Professor of Pharmacy Practice, Purdue University/Eskenazi Health, Indianapolis, IN, and Chris Paxos, Pharmacotherapy Specialist, Cleveland Clinic Akron General, Akron, OH
  • Student Committee: Azita Alipour, PharmD, BCPP, Assistant Professor, Marshall B. Ketchum University College of Pharmacy, Fullerton, CA
  • Substance Use Disorders Committee: Bethany DiPaula, PharmD, BCPP, Associate Professor/Director of Pharmacy, University of Maryland, Sykesville, MD
  • USP 800 Compliance Editorial Board: Ann Richards, Pharmacy Director, San Antonio State Hospital & Texas Department of State Health Services, San Antonio, TX
  • Value Paper Task Force: Amy Werremeyer, PharmD, BCPP, Associate Professor, Dept. of Pharmacy Practice; Clinical Specialist in Psychiatry, North Dakota State University, Fargo, ND
  • Vision Paper Task Force: Lisa Goldstone, PharmD, BCPS, BCPP, Associate Professor of Clinical Pharmacy/Associate Director of Residency Programs, University of Southern California School of Pharmacy, Los Angeles, CA
A special thanks to all of these individuals who serve the CPNP membership and the profession as a whole. You are always welcome to share input and ideas to CPNP staff or any leader on the board or committees. Contact information is available online for committees and the Board
Return to The CPNP Perspective issue main page.< Previous Article